...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
【24h】

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

机译:不相关的供体移植中,MHC I类链相关基因A的供体-受体错配导致急性移植物抗宿主病的发生率增加。

获取原文
获取原文并翻译 | 示例
           

摘要

The polymorphic products of major histocompatibility complex class I-related chain A (MICA) genes are important in solid organ transplantation rejection. MICA expression is limited to gut epithelium and may play a role in triggering acute graft-versus-host disease (aGVHD). A total of 236 recipients of unrelated donor transplantation were studied. Donor-recipient human leukocyte antigen (HLA) match was 10/10 human leukocyte antigen (HLA-A, -B, -C, -DRB1, -DQB1) in 73% and MICA mismatch in 8.4%. Because of physical vicinity of the loci, MICA mismatch was significantly associated with mismatch at HLA-B and HLA-C. A higher rate of grade II-IV aGVHD was seen in MICA-mismatched patients (80% vs 40%, P = .003) irrespective of degree of HLA matching (HLA 10/10 match: 75% vs 39%, P = .02) and HLA any mismatch (83% vs 46%, P = .003). The rate of grade II-IV gastrointestinal aGVHD was also higher in MICA-mismatched patients (35% vs 17%, P = .05). We conclude that MICA may represent novel a transplantation antigen recognized by human allogeneic T cells. This study was registered at ClinicalTrials.gov (Identifier NCT00506922).
机译:主要组织相容性复杂的I类相关链A(MICA)基因的多态性产物在实体器官移植排斥中很重要。 MICA的表达仅限于肠道上皮,并且可能在引发急性移植物抗宿主病(aGVHD)中发挥作用。共研究了236名无关供体移植的接受者。供者接受的人白细胞抗原(HLA)匹配为10/10,其中人白细胞抗原(HLA-A,-B,-C,-DRB1,-DQB1)占73%,MICA失配率为8.4%。由于基因座的物理附近,MICA错配与HLA-B和HLA-C的错配显着相关。无论HLA匹配程度如何(HLA 10/10匹配:75%vs 39%,P =),在MICA不匹配患者中观察到II-IV aGVHD的发生率更高(80%vs 40%,P = .003)。 02)和HLA的任何不匹配(83%vs 46%,P = .003)。在MICA不匹配的患者中,II-IV级胃肠道aGVHD的发生率也更高(35%对17%,P = 0.05)。我们得出的结论是,MICA可能代表了人类同种异体T细胞识别的新型移植抗原。该研究已在ClinicalTrials.gov上注册(标识符NCT00506922)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号